10/14 science / biotechnologies news stories aggregated by FeedZilla.com

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. science / biotechnologies news stories aggregated by FeedZilla.com The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc. (source: prnewswire.com) October 13, 2009 at 4:36 pm RESEARCH TRIANGLE PARK, N.C. and MIAMI, Oct. 13 /PRNewswire-FirstCall/ -- The Alpha-1 Foundation announced today that it has awarded two research grants to study how genetic variations in the alpha-1 antitrypsin (AAT) gene contribute to lung and liver dama... (source: prnewswire.com) - News widgets and RSS feeds on Feedzilla.com Cepheid Schedules 2009 Third Quarter Financial Results Announcement and Webcast (source: prnewswire.com) October 13, 2009 at 4:05 pm SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its third quarter ended September 30, 2009, on Wednesday, October 28, 2009, after the close of the market. (source: prnewswire.com) - RSS widgets and RSS feeds on Feedzilla.com Amylin Pharmaceuticals to Webcast Third Quarter Results (source: prnewswire.com) October 13, 2009 at 4:05 pm SAN DIEGO, Calif., Oct. 13, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the third quarter of 2009 on Tuesday, October 20, 2009 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Brad... (source: prnewswire.com) - News widgets and RSS feeds on Feedzilla.com Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations (source: prnewswire.com) October 13, 2009 at 4:05 pm SUNNYVALE, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Nicolaas ('Nico') Arnold to the position of Executive Vice President of Worldwide Commercial Operations, effective October 14, 2009. The ... (source: prnewswire.com) - RSS news feeds and Widgets on Feedzilla.com Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R) (source: prnewswire.com) October 13, 2009 at 12:06 pm PHILADELPHIA, October 13 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc. ("Sandoz") in connection with Sandoz's Abbreviate... (source: prnewswire.com) - News widgets and RSS feeds on Feedzilla.com The first neotropical rainforest was home of the Titanoboa (source: LifeSciencesWorld.com) October 13, 2009 at 11:40 am [NEWS] Smithsonian researchers working in Colombia's Cerrejón coal mine have unearthed the first megafossil evidence of a neotropical rainforest. Titanoboa, the world's biggest snake, lived in this forest 58 million years ago at temperatures 3-5 C wa... (source: LifeSciencesWorld.com) - News widgets and RSS feeds on Feedzilla.com BIOSAFE Launching In a New Specially-Treated Facemask Effective Against H1N1 Influenza (source: prnewswire.com) October 13, 2009 at 11:36 am PITTSBURGH, Oct. 13 /PRNewswire/ -- BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®... (source: prnewswire.com) - RSS feeds and Feed widget on Feedzilla.com 23andMe Tests NFL Players' DNA for Athletic Genetic Factors (source: prnewswire.com) October 13, 2009 at 11:05 am MOUNTAIN VIEW, Calif., Oct. 13 /PRNewswire/ -- 23andMe, Inc., an industry leader in personal genetics, conducted the genetic analysis of both former and current NFL players, as well as scientific controls, to investigate how genes impact athletic performan... (source: prnewswire.com) - News widgets and RSS feeds on Feedzilla.com CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator (source: prnewswire.com) October 13, 2009 at 11:00 am SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- CareFusion Corporation (NYSE: CFN), a new clinical and medical products corporation, today announced the launch of the EnVe(TM) ventilator - a high-performance critical care ventilator for pediatric and adult pa... (source: prnewswire.com) - RSS and News widget on Feedzilla.com ATS Medical Announces Receipt of CE Mark for the New ATS CryoMaze 10-S Probe (source: prnewswire.com) October 13, 2009 at 6:30 am MINNEAPOLIS, Oct. 13 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the receipt of CE Mark for the ATS CryoMaze® 10-S Surgical Cryoablati... (source: prnewswire.com) - RSS feeds and Feed widget on Feedzilla.com Cequent to Provide Details at BIOCOM About Planned Launch of its Clinical Program - 3 p.m., Tuesday, October 27 (source: prnewswire.com) October 13, 2009 at 5:00 am CAMBRIDGE, Mass., Oct. 13 /PRNewswire/ -- Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Chief Executive Officer, Peter Parker, will provide detail... (source: prnewswire.com) - RSS and News widget on Feedzilla.com Ipsen and Debiopharm Group Announce That Decapeptyl(R)(triptorelin embonate) 6-month Successfully Completes the European Decentralised Procedure for the Treatment of Locally Advanced or Metastatic Prostate Cancer (source: prnewswire.com) October 13, 2009 at 1:30 am LAUSANNE, Switzerland and PARIS, October 13 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext:... (source: prnewswire.com) - RSS and News widget on Feedzilla.com SAFC Pharma Installs the Industry's First Commercial Dual Wavelength X-Ray Diffractometer (source: prnewswire.com) October 13, 2009 at 1:00 am ST. LOUIS and MADRID, Oct. 13 /PRNewswire-FirstCall/ -- CPhI -- SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group (Nasdaq: SIAL), today announced that its Pharmorphix® Solid State Research Laboratories in C... (source: prnewswire.com) - RSS news feeds and Widgets on Feedzilla.com SAFC Pharma(R) Announces Completion of $12M Contract Manufacturing Facility Expansion in Carlsbad, Calif. (source: prnewswire.com) October 13, 2009 at 1:00 am ST. LOUIS, Oct. 13 /PRNewswire-FirstCall/ -- SAFC Pharma®, a business segment of SAFC®, a member of the Sigma-Aldrich® Group (Nasdaq: SIAL), today announced the completion of an addition to its Carlsbad, Calif., facility that expands the Com... (source: prnewswire.com) - News widgets and RSS feeds on Feedzilla.com AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy (source: prnewswire.com) October 13, 2009 at 1:00 am AMSTERDAM, October 13 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy prod... (source: prnewswire.com) - RSS news feeds and Widgets on Feedzilla.com   This email was sent to 4ndr1fm@gmail.com.  Manage Your Account Don't want to receive this feed any longer? Unsubscribe here.